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Background Angioscopy surpasses other diagnostic tools, such as angiography and intravascular ultrasound, in detecting 
arterial thrombus. This capability arises in part from the unique ability of angioscopy to assess true color during imaging. In 
practice, hardware-induced chromatic distortions and the subjectivity of human color perception substantially limit the 
theoretic potential of angioscopic color. We used a novel application of tristimulus colorimetry to quantify thrombus color 
to both aid in its detection and assess its composition. 
Methods and Results A series of human thrombus models were constructed in vitro. Spatial homogeneity was ensured by 
light and electron microscopy. Quantitative colorimetric angioscopic analysis demonstrated excellent measurement reproducibility (mean 
difference, 0.07% to 0.17%), unaffected by illuminating light intensity (coefficient of variation, 0.21% to 3.67%). Colorimetric parameters C1 
and C2 were strongly correlated (r=.99, P<.0001) with thrombus erythrocyte concentration. Principal components analysis transformed these 
parameters into a single value, the thrombus erythrocyte index, with little (0.06%) loss of content. Measured and predicted concentrations were 
similar (mean difference, 0.16 erythrocytes per 1 ng). Randomly ordered images were also subjected to visual analysis by three experienced 
angioscopists, with suboptimal levels of both intraobserver (mean =0.63) and interobserver (mean =0.48) agreement. In addition, visual 
ranking resulted in a Kendall rank coefficient of 0.72 to 0.76 versus a perfect 1.00 from quantitative measurement. 
Conclusions Quantitative colorimetric angioscopic analysis provides a new, objective, and reproducible analytic tool for assessing angioscopic 
images of human thrombus. Even under ideal circumstances, experienced angioscopists do a poor job of assessing color (and therefore 
composition) of human thrombi. This technique can, for the first time, provide quantitative information of thrombus composition during routine 
diagnostic imaging. 
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The presence of thrombus in the coronary arterial tree has long been recognized by pathologists as a common finding in 
postmortem hearts.1 2 However, it was the classic work of DeWood and colleagues3 in 1980 that firmly established the 
etiological role of thrombus in the genesis of acute myocardial infarction. More recent investigations have also identified 
thrombus as a prominent feature of unstable angina.4 5 6 7 8 This recognition has led to the successful treatment of this 
common disorder with agents that interfere with the clotting process.9 10 11 12 13 14 15 Current thinking now places thrombus 
at a pivotal position in nearly all acute coronary syndromes.16 
Part of the past controversy regarding intracoronary thrombosis arises from the difficulty of its detection in the living heart. Contrast 
angiography remains the most widely used technique for characterizing coronary pathology. However, thrombus that projects into the vascular 
lumen is generally surrounded by contrast medium, resulting in a roentgenographic silhouette that frequently masks its presence. Mural 
thrombus avoids this problem through its adherence to the vessel wall. Its detection is far from assured, however, because angiography can 
characterize only the arterial lumen and not the adjacent structures. Finally, even if a filling defect is visualized, angiography cannot reliably 
distinguish thrombus from other common intracoronary structures such as plaques, dissections, or intimal flaps. 
Newer imaging techniques such as intravascular ultrasound have the advantage of producing topographic rather that silhouette representations 
and can interrogate tissues beneath the luminal border.17 Thrombus, though, possesses an acoustic density that differs only slightly from nearby 
normal and abnormal tissues, making a positive identification particularly difficult.18 It is also possible to use approaches that specifically search 
for the presence or absence of thrombus. Indium-labeled platelet imaging represents a good example of a procedure that has been quite 
successful in identifying thrombus localized to the chambers of the heart.19 20 Attempts to extrapolate these impressive results to the detection of 
thrombus confined to the coronary vasculature have been disappointing, however, likely because of the small mass of thrombus involved.21 
Angioscopy has been shown to represent a useful technique in the recognition of intracoronary thrombus.7 22 23 24 25 26 27 28 29 30 31 Indeed, 
thrombus detection may prove to be the most important clinical capability of this emerging diagnostic procedure. Angioscopy presents several 
features that make it uniquely suited to this role. First, its interrogative capabilities are confined to the intraluminal space and surrounding 
endoluminal surface. This is precisely the area where occlusive coronary thrombi are generated and located. Second, unlike other techniques, 
angioscopy can, in a single image, visualize a major portion of the surface of a thrombus. This enhances one's ability to distinguish thrombus 
from other protruding structures such as atheroma. Third, angioscopy provides a spatial resolution, measured in our laboratory, of 50 µm. This 
compares favorably to resolutions of 200 µm for angiography32 and 150 µm for intravascular ultrasound.33 Finally, angioscopy represents the 
only diagnostic technique in cardiology capable of providing information on true color. Because the color of thrombus frequently differs from 
that of surrounding structures, better diagnostic specificity is realized. 
In the current study, we investigated whether the composition of a human thrombus could be ascertained through characterization of the light 
reflected from its surface. This was accomplished using a new tool developed in our laboratory specifically for the quantification of images 
obtained during angioscopy. 
 









Creation of Thrombus Model 
A series of static human thrombus models were constructed in vitro. Blood was collected at room temperature from a single 
healthy donor using a large-bore intravenous needle. The donor was not using chronic medications or birth control pills and 
had not taken aspirin for at least 30 days before donation. All studies were performed in accordance with the guidelines of 
the Institutional Review Board. An anticoagulant, consisting of 0.8% citric acid, 2.2% sodium citrate, and 2.25% glucose, 
was continually mixed with the blood during collection achieving a final concentration of 6%. Immediately after collection, 
platelet-rich plasma was created by centrifugation of anticoagulated blood at 450g for 20 minutes at 23°C. After removal of 
the supernatant, the remaining mixture was centrifuged at 20 000g for 10 minutes at 4°C to produce platelet-free plasma. Appropriate volumes 
of platelet-rich and platelet-free plasma were combined to create plasma with a plasma platelet concentration identical to that of the original 
anticoagulated blood sample. The integrity of the erythrocytes subjected to the separation process was verified by the confirmation of a plasma-
free hemoglobin concentration of <10 µg/L obtained from all samples of blood and plasma. 
The thrombi were formed in a series of 12-mm-diameter cylindrical polystyrene containers held in a 37°C water bath. By use of a precision 
micropipette (rated accuracy ±1.0%), appropriate volumes of the plasma mixture and blood were combined to produce 18 different erythrocyte 
concentrations. The final target concentrations of erythrocytes in the cylinders, relative to the original anticoagulated blood, were 100%, 80%, 
60%, 40%, 30%, 25%, 20%, 15%, 12%, 8%, 6%, 4%, 2%, 1%, 0.5%, 0.2%, 0.1%, and 0%. After mixing, each mixture was maintained at 37°C 
for 45 minutes before clotting to enhance platelet activation. Before clotting, a 700-µL aliquot of each mixture was sent for assessment of the 
concentration of erythrocytes, leukocytes, and fibrinogen. Clotting was initiated with the addition of 230 µL of 0.2 mol/L calcium chloride, 
resulting in a final volume of blood mixture of 4530 µL in each cylinder. During clotting, each cylinder was gently agitated at 3-minute intervals 
to prevent cell settling, and each was capped to prevent the loss of CO2 with a resultant change in pH. All clots were maintained at 37°C for a 
minimum of 18 hours to allow sufficient time for full clot retraction. 
The formed thrombus models were removed, accurately weighed, and submerged in Michaelis buffer (sodium acetate and sodium 5,5-
diethylbarbiturate titrated to a pH of 7.42)34 contained in a Petri dish. The serum was used for determining the concentration of remaining 
formed elements and fibrinogen. Each thrombus model was then photographed using constant lighting conditions, exposure settings, and object 
distance. 
Composition of Thrombus Models 
The concentration of erythrocytes, leukocytes, platelets, and fibrin contained in each thrombus model was computed by use of the differences in 
volume and concentration of the blood/plasma mixture before clotting and the serum after clotting. These values were computed in absolute 
terms as a quantity per thrombus and in relative terms per gram of thrombus material. Spatial homogeneity was assessed by light microscopy of 
a 5-µm-thick vertical section cut along a diameter of each cylindrical thrombus model. Examination of these sections prepared with Goldner 
stain permitted assessment of the relative content of each formed element at the top surface (remote from container wall), at the bottom and side 
surfaces (adjacent to container wall), and at various depths within the thrombus model. The ultrastructure was assessed with electron microscopy 
of glutaraldehyde-fixed sections of each thrombus model. 
Angioscopic Imaging 
A custom test setup was designed and constructed for in vitro imaging of the thrombus models (Fig 1 ). Angioscopic imaging was 
accomplished with a new 4.5F Baxter ImageCath coronary angioscope. Before testing, a camera white balance was performed during imaging of 
an equal-energy white color standard (Spectralon, Labsphere); the resulting white image was also recorded for the derivation of correction 
factors detailed below. Two 0.3-mm-diameter steel pins were mounted at the tip of the setup device just outside the image field. These pins were 
brought into contact with the surface of the thrombus model undergoing angioscopic imaging, thereby maintaining a fixed and reproducible 1.7-
mm distance from angioscope tip to object surface. All imaging was accomplished with the angioscope tip and thrombus model submerged in a 
buffer solution to reduce surface reflection and more closely approximate in vivo imaging conditions. A flat black background was used to 
minimize reflection of any traversing light energy. The thrombi were illuminated through the angioscope with a 300-W xenon light source 
(Baxter model OPTX 300), and the image was captured on an Envision model 2705 single-chip, 1/3–in (8.38-mm) CCD video camera with the 
automatic shutter control disabled to prevent autoregulation of light level. To permit subsequent off-line analysis, all images were recorded on 
0.5-in super VHS videotape using the "Y/C" video signal. Imaging was performed in a fully darkened room with the angioscope shielded from 
stray light emanating from the light source ventilation ports or video monitor screens. 
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Figure 1. Setup for quantitative measurement of thrombus models. A, Tip of angioscopic 
catheter is held inside plastic housing. The two 1.7-mm positioning pins can be seen above the 
submerged thrombus model, located on either side of the circle of illumination. B, Same setup 
as observed during actual imaging.
All thrombi models were oriented so that imaging was performed on the top surface of the clot, an area not in contact with the container wall 
during the final stages of clotting. Each thrombus model was imaged four times, once at each of four light intensity settings. The settings used 
were held constant for all testing and were selected to provide a wide range of light intensities while maintaining the mean luminosity values 
within the valid working range as previously established in our laboratory.35 To assess the homogeneity of the thrombus model, each thrombus 
was bisected after completion of surface imaging and a new image obtained from its center. 
Image Processing and Analysis System 
Tristimulus colorimetric measurements were made from the images of the thrombus models using the quantitative colorimetric angioscopic 
analysis system developed in our laboratory. Detailed descriptions of this system have been published previously.35 36 In brief, video images 
obtained either directly from the camera or from videotape were digitally sampled by use of a fast 24-bit (8 bit per channel) analog-to-digital 
conversion system. This system permits real-time (1/25 second) digitization in 16.7 million colors and provides a spatial resolution of 720x576 
for PAL (720x480 for NTSC). Single-frame images were acquired and stored on a microcomputer in a 640x480x24-bit-deep bit map format. A 
custom image analysis program permitted the user to select a rectangular region of interest intended for quantitative colorimetric analysis. Red, 
green, and blue (RGB) color values for each picture element (pixel) contained within the selected region were computed. These values were 
corrected for errors inherent to the hardware imaging chain by use of three sequentially applied algorithms (color-dependent offset value, 
software-derived "white balance," and exponential gamma correction). The corrected RGB values were transformed into two other chromaticity 
coordinate systems. The first, known as the HSI color space, allows a color to be completely described by hue, saturation, and intensity. The 
second, the C diagram, was developed in our laboratory specifically for angioscopic imaging.35 In this system, color that is independent of light 
intensity is completely defined by two parameters, C1 (an intensity-independent red index) and C2 (an intensity-independent green index). These 
colorimetric parameters were normalized to provide a full range of 0 to 1. 
All image analyses were performed without knowledge of the composition of the thrombus models. To maximize objectivity, a predefined and 
reproducible region of interest for quantitative measurement was used for all images. 
Visual Interpretation of Thrombus Models 
To assess the accuracy of visual discrimination of color between the thrombus models, three experienced angioscopists were asked to blindly 
grade and order the color of all images of the erythrocyte thrombus models containing a thrombus erythrocyte concentration of 8 cells per 1 ng 
or less. None of these individuals were involved with either the creation or imaging of the thrombus models. To accomplish this task, each 
expert was presented with 44 images of the 11 thrombus models, each recorded at four different light intensities. The order of presentation was 
set randomly by a computer-generated random number table, and the images were shown sequentially for 5 seconds with a 5-second pause 
between images. The experts were asked to order the images from the greatest to least concentration of erythrocytes, as well as assign each 
thrombus model to one of five ordered color categories: red, whitish-red, red-white, reddish-white, and white. 
Data Analyses 
Continuous variables were analyzed by use of the two-tailed t test. Linear and nonlinear regression techniques were used to explore the relations 
between different colorimetric indexes, as well as in the construction of a model predictive of thrombus erythrocyte concentration. 
Multidimensional data were reduced to a single dimension by principal components analysis. To assess observer agreement, the  statistic was 
used to assess the magnitude of differences found both between and within observers. The accuracy of ranking of angioscopic images was 
analyzed using Kendall's rank correlation. Two-way ANOVA was used to investigate the relation between illuminating light intensity and visual 
ranking of thrombus model color. Plus-minus values represent mean±SD. Mean differences associated with a value of P<.05 were deemed 
statistically significant. 
 









Thrombus Model Creation 
A total of 18 human thrombus models were created in vitro under static flow conditions. The composition of each was 
designed to reflect decreasing concentrations of erythrocytes relative to the number of platelets. This was accomplished by 
sequentially decreasing the number of erythrocytes in the preclot mixture while maintaining a nearly constant plasma 
platelet concentration. Table 1  provides the target proportion of whole anticoagulated blood planned in the final mixture, 
as well as the actual measured concentration of elements and fibrinogen determined before clotting. The values reflect a 
serially diminishing hematocrit and concentrations of erythrocytes and leukocytes while maintaining a steady plasma 
fibrinogen and platelet concentration. 
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Table 1. Concentrations in Initial Blood/Plasma Mixtures
A comparison between planned and observed erythrocyte parameters is provided in Table 2 . Note that the differences between measured and 
predicted values were small, averaging -0.07±0.34% for hematocrit and -0.42±0.59% for hemoglobin. This confirms the accuracy of the 
procedure in achieving the desired erythrocyte concentrations. 
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Table 2. Accuracy of Measured Versus Expected Erythrocyte Parameters
The final composition of each thrombus model was computed by use of the difference in absolute amounts of its component constituents 
between the preclot mixture and the postclot serum (Table 3 ). In the first 12 thrombus models, a measurable number of erythrocytes remained 
in the serum after clotting. Nearly all the platelets present in the preclotting mixture were incorporated into the thrombus models, with 
measurable serum quantities found in only 3 samples. All measurable quantities of fibrinogen were consumed in all samples during the clotting 
process. 
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Table 3. Absolute Quantity of Thrombus Constituents Determined by Difference in Initial Blood and Final Serum 
Values
Although the volume of preclot mixture was held constant for each thrombus model, the final weight of the thrombi after clotting differed 
significantly (Table 4 ), ranging from 0.35 to 1.72 g. To correct for these size differences, the absolute number of formed elements contained in 
each thrombus model was normalized by weight as shown in Table 4 . As expected, the resulting concentration of erythrocytes differed more 
than a 100-fold from thrombus 1 to 18 (9.59 versus 0.08 per 1 ng), with more modest differences observed in platelet concentrations (0.47 
versus 1.74 per 1 ng). 
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Table 4. Concentration of Erythrocytes and Platelets in Thrombus Models
Assessment of Measurement Variability 
Each thrombus model was imaged during submersion by use of an angioscope model in common clinical use. The circular image obtained at the 
object-to-catheter distance used in this study was 3.4 mm in diameter. Colorimetric measurement reproducibility was assessed by analysis of 
three sequentially acquired images obtained from each of 11 randomly selected thrombus models. The values obtained were found to be 
reproducible during serial imaging, with an SD of 0.002 for C1 values and 0.001 for C2 values. This corresponded to a mean absolute difference 
of 0.17±0.13% and 0.07±0.05% for C1 for C2, respectively. 
It is also important to ensure that the colorimetric values obtained are relatively independent of color intensity, because this latter parameter is 
highly dependent on both the brightness of the illumination source and the object-to-catheter distance. For this evaluation, serial images were 
obtained while illumination intensity was varied at the light source over the entire range of clinically useful levels of brightness. Colorimetric 
analysis of the 72 images obtained (4 per thrombus model) revealed a mean SD below 0.007 for all four colorimetric parameters. Corresponding 
coefficients of variation (mean±SD) were 1.00±0.79% and 3.67±1.53% for C1 and C2 and were even smaller for hue and saturation (0.21±0.32% 
and 2.67±3.15%, respectively). Hence, illumination intensity had little impact on the colorimetric values obtained in this study. 
Assessment of Color Heterogeneity 
Color heterogeneity of the thrombi was assessed in two ways. First, local heterogeneity was examined with 25 contiguous regions of interest 
positioned in a 5x5 square matrix and applied to images obtained from each thrombus model, with the size of each region measuring 0.32 mm 
(true scale) in length and width. Colorimetric analysis of all these 450 regions produced a mean coefficient of variation per thrombus model of 
2.71% for C1 and 4.07% for C2. Second, to examine possible differences between the surface and interior of the thrombus, each thrombus model 
was imaged at its center after bisection as well as at its surface. The colorimetric values obtained from these two different areas revealed a mean 
difference of -0.04±0.06 for C1 and +0.02±0.03 for C2. These data suggest that the color assessed by quantitative colorimetric angioscopic 
analysis is relatively homogeneous throughout each thrombus model and that measurement at one site is representative of the thrombus overall. 
Histological homogeneity was verified by microscopy (Figs 2  and 3 ). 
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Figure 2. Representative thrombus model (No. 8) containing a relatively high concentration of 
erythrocytes (5.31 ng-1). A, Photograph of thrombus submerged in buffer solution 
superimposed on a 1-mm grid. B, Image obtained through angioscope and used for 
quantitative colorimetric measurements. C, Electron micrograph of thrombus, revealing a large 
number of tightly packed erythrocytes (arrow). D, Photomicrograph using Goldner stain, 
demonstrating densely packed erythrocytes with little surrounding matrix.
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Figure 3. Representative thrombus model (No. 16) containing a relatively low concentration 
of erythrocytes (0.20 ng-1). A, Photograph of thrombus submerged in buffer solution 
superimposed on a 1-mm grid. B, Image obtained through angioscope and used for 
quantitative colorimetric measurements. C, Electron micrograph of thrombus, revealing rare 
isolated erythrocytes surrounded by single and clumped platelets (solid arrow) and strands of 
polymerized fibrin (open arrow). D, Photomicrograph using Goldner stain, showing a single 
erythrocyte with dense platelets and fibrin in the surrounding matrix.
Relation of Colorimetric Measurements to Thrombus Models 
The C1 and C2 colorimetric values obtained from the thrombus models are graphically depicted in Fig 4 . Starting from thrombus 9, C1 (the red 
index) demonstrates a progressive decrease, and C2 (the green index) demonstrates a progressive increase in value with decreasing amounts of 
erythrocytes in the preclot mixture. These values converge near but not at the white point (C1=C2=0.333). In contrast, the thrombus models 
generated from mixtures containing 100% to 15% blood (thrombus 1 through 8) reveal no apparent change over this range. 
 
 
View larger version (15K): 
[in this window] 
[in a new window] 
  
Figure 4. C1 (red value normalized by intensity) and C2 (green value normalized by intensity) 
colorimetry values ordered by the number of the thrombus model. Erythrocyte concentration 
decreases as the thrombus number increases. Values represent means of four measurements of 
thrombus model images recorded at four different illumination light intensities. In this format, 
true white is indicated by the point where C1 and C2 each equal 0.333. A single outlier (No. 
14) has been excluded in this and subsequent graphs unless otherwise stated.
Fig 5  displays the relation between the color intensity value and thrombus number. A minor linear increase in intensity is evident (r=.74) as the 
number of erythrocytes in the preclot mixture decreases. Although this trend is statistically significant (P<.001), the extent of scatter of the 
individual values is large enough to preclude useful predictive power (standard error of the estimate, 13.8). Thus, colorimetric differentiation of 
the thrombus models was well characterized by C1 and C2 values, with little useful discriminating information provided by intensity. 
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Figure 5. Colorimetric intensity values ordered by the number of the thrombus model. Also 
shown is the line of linear regression, with r=.738, SEE=13.8, intercept=24.8, slope=2.71, and 
P<.001.
Optimal Characterization of Thrombus Color 
The results of the quantitative colorimetric measurements obtained from the thrombus models can be described using several different color 
coordinate systems. Fig 6  shows a polar plot of the colorimetric values of the thrombus model, with hue presented in angular values and 
saturation in radial values. Saturation varied over most (75.0%) of its possible range and provided most of the variability that distinguished one 
thrombus model from another. 
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Figure 6. Polar plot of colorimetric values for the thrombus models, presented in the hue, 
saturation, and intensity color space. Hue is represented as angular values, and saturation as 
radial values. Intensity is not shown but if present would be plotted as a third dimension 
extending through the center of the graph perpendicular to the plane of the page. For 
orientation, red hue is located at 0°, green hue at 120°, and blue hue at 240°. Labels are shown 
for the two thrombus models obtained from the preclot mixtures with the greatest (No. 1) and 
least (No. 18) concentration of erythrocytes.
The C1/C2 chromaticity diagram provides an alternative descriptive format (Fig 7 ). With this triangular coordinate system, red colors are 
located in the lower right corner, green in the upper left corner, and blue in the lower left corner. The thrombus models in the current study range 
in color from a strong red (thrombus 1) to a white with a slight cyan-blue tint (thrombus 18). 
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Figure 7. Mean colorimetric values plotted for each thrombus model using the C1/C2 
chromaticity diagram. Neutral color (white) is indicated by a cross. Labels are shown for the 
two thrombus models obtained from the preclot mixtures with the greatest (No. 1) and least 
(No. 18) concentration of erythrocytes.
Creation of a Predictive Model 
It is important to note that in Fig 7  the observed values occupy a nearly linear (r=.998) distribution. This pattern permitted the reduction of the 
two-dimensional data shown in this figure into a single dimension, thereby permitting the differentiation of the thrombi using a more convenient 
single parameter. Principal components analysis was used to achieve this transformation. This process was accomplished with little loss of 
predictive accuracy, because the first principal component in this model by itself accounted for 99.94% of the total observed variance. The 
resulting model was weighed more heavily toward C1 than C2, with linear coefficients of .907 and -.422, respectively. 
A final goal was the transformation of this colorimetry-derived parameter into a more direct and clinically relevant descriptor of thrombus 
composition such as the number of erythrocytes contained within a nanogram of thrombus material. This allowed the creation of a final model 
that predicted the concentration of erythrocytes in a given thrombus based solely on measured C1 and C2 values. The final predictive equation is 
provided below:  
where TEI represents the colorimetry-derived thrombus erythrocyte index. Fig 8  graphically compares the colorimetric estimates of 
erythrocyte concentrations of the thrombus models with actual measured values. The mean difference between estimated and measured values 
was small (0.16 erythrocytes per 1 ng). 
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Figure 8. Logarithmic plot of thrombus erythrocyte index derived from colorimetric analysis 
shown on the y axis and actual measured concentration of erythrocytes shown on the x axis. 
Dashed line represents the line of identity, and data points represent the 11 thrombus models 
used for visual analysis.
Comparison of Quantitative and Visual Categorization and Ranking 
 statistics were used to assess the magnitude of observer agreement in the 44 randomly ordered images. Using a five-point ordinal color scale, 
the assessment of intraobserver variability revealed  values ranging from 0.57 to 0.73, with a mean of 0.63. Analogous  values for 
interobserver variability were somewhat lower, with a mean of 0.48 (range, 0.34 to 0.70). None of the individual  values obtained fell into a 
range generally considered to indicate good observer agreement (ie, >0.75). 
In addition to comparing color categories, the sequentially displayed images were ranked, allowing comparisons not only between different 
observers but also between observers and the quantitative analysis system. Each angioscopist was asked to rank the 44 randomly presented 
images from the highest to lowest concentration of erythrocytes on the basis of color. A second reading of the entire set of images immediately 
followed the first. These same images were also subjected to quantitative colorimetric analysis, during which they were ranked on the basis of 
computed thrombus erythrocyte index values. Calculation of the Kendall rank correlation coefficient permitted assessment of the accuracy of the 
ranking using the measured thrombus erythrocyte concentration as the standard for comparison. A Kendall coefficient of 1.00 indicates a 
completely accurate ranking, whereas a value of 0.00 is anticipated for a ranking done solely by chance. In this study, the coefficients obtained 
from the first rankings of the three trained observers were 0.68, 0.74, and 0.76 (mean, 0.72). The values for the second reading were each 
slightly better (0.72, 0.75, and 0.81 with a mean of 0.76), suggesting the possibility of a training effect. Compared with these scores, the 
quantitative colorimetric angioscopic analysis system produced a Kendall rank correlation coefficient of 1.00, indicating a completely accurate 
ranking of all 44 angioscopic images. 
Because each thrombus model was imaged with four different light intensities, it was possible to ascertain whether light intensity itself 
systematically influences the visual interpretation or quantitative measurement of thrombus color and composition. Similar mean thrombus 
rankings at each intensity would be expected if visual interpretation were unaffected. However, the mean visual rankings decreased 
progressively (24.6 to 23.6 to 22.7 to 21.6) as the light intensity decreased from its highest to its lowest value (P=.007). This trend was seen 
individually for all three observers as well. This finding suggests that trained observers tend to rate the erythrocyte concentration as erroneously 
high in images that are dimly lit and erroneously low in images that are brightly lit. This pattern of error was not observed with the quantitative 
colorimetric analysis system, which reported values uninfluenced by light intensity. 
 









Importance of Thrombus Composition 
Intracoronary thrombus should not be viewed as a single entity with uniform characteristics and behavior. Rather, its 
composition may vary considerably, depending on the clinical milieu present at the time of its creation. Pathologists have 
for decades dichotomized thrombi into the categories of "red" and "white" on the basis of their gross appearance.37 The 
color difference appears to arise from the relative number of erythrocytes and platelets present. This distinction represents 
more than a pathological convenience. In 1992, Mizuno and coworkers23 reported that intracoronary thrombi were 
angioscopically visualized in 94% of all patients who presented with acute coronary syndromes. Importantly, in 10 of 14 
patients with unstable angina, the observed thrombi were grayish-white, whereas in all 15 patients with acute myocardial infarction, the thrombi 
were reddish. Hence, thrombus color might be different in these two important coronary syndromes. 
In addition to its diagnostic importance, knowledge of thrombus composition has therapeutic implications. Jang et al38 have reported on the 
differential sensitivity of erythrocyte-rich and platelet-rich thrombi to lysis using tissue-type plasminogen activator. This difference may account 
for the apparent paradox of a clearly favorable response to attempted thrombolysis seen in acute myocardial infarction39 40 and the repeatedly 
poor response observed in unstable angina,12 41 despite the fact that both syndromes are presumably initiated by coronary thrombus formation. 
Foreknowledge of the relative sensitivity to drug-induced lysis of a given thrombus would be extremely useful to a cardiac interventionalist. A 
procedure complicated by acute thrombosis could then be most appropriately treated with intracoronary lytic agents or further mechanical 
intervention. 
Interpretation of Thrombus Color 
Despite the potentially important role of color in enhancing the diagnostic abilities of angioscopy, two major practical problems exist that could 
greatly limit its substantial theoretic utility. First, the color of an object as viewed on a video screen can differ markedly from its true color. The 
light source, the angioscopic imaging bundle, the white balance and gamma correction algorithms used by the camera, the format of video 
modulation, the linearity of the recording device, and the manual settings of the monitor color controls can all induce significant errors in color 
accuracy.36 Unfortunately, the impetus driving the development of video methodology and standards used in angioscopy has not been scientific 
concerns but the consumer market in which physically accurate color rendition may not be important or even desirable. The second practical 
problem involves the interpretation of color. Because of the complexities and individualities of color perception, each observer interprets and 
describes color in unique terms. This has led to many creative but imprecise angioscopic descriptions of thrombus color reported in the literature 
such as an appearance consistent with "tomato puree."42 The magnitude of this limitation was recently highlighted by the European Working 
Group on Coronary Angioscopy.43 This group studied observer variability in the classification of findings derived from 30 clinical angioscopic 
procedures. Despite the elimination of color rendition errors discussed above, the  values for chance corrected intraobserver and interobserver 
color variabilities were among the lowest recorded for any category (  range, 0.29 to 0.82 and -0.04 to 0.52, respectively), including some 
interobserver values that were worse than predicted by chance alone. When the equipment-related color distortions occurring at multiple levels 
of the imaging chain are combined with the marked subjectivity of color perception, the visual interpretation of angioscopic color as currently 
practiced would appear to have limited clinical utility. 
These limitations provided the impetus for the creation of a quantitative approach to color measurement. The precision of the quantitative 
colorimetric angioscopic analysis system developed in our laboratory has been validated previously.35 36 
Thrombus Models 
This study demonstrates that human thrombus models can be constructed in vitro to provide a cellular composition varying over a wide range in 
a predictable manner. These models appear to display a high degree of spatial homogeneity, as gauged by both histological evaluation and 
surface/interior color measurement. Sequential imaging and quantitative colorimetric measurement of the models provided repeatable values, 
with all absolute differences averaging <0.2%. 
The C1 and C2 colorimetric values obtained were nearly independent of illumination intensity (SD <0.007). This observation is important if this 
technique is to be applied to clinical angioscopy. Illumination intensity is determined by the interaction of power output of the light source and 
the square of the object-to-catheter-tip distance. The former variable can be controlled. However, object distance during in vivo intraarterial 
imaging is impossible to fix and difficult to measure. Structures viewed at a distance visually appear to have a darker color than when viewed 
near the angioscope tip. Quantitative colorimetric analysis avoids this pitfall in color assessment. Unlike clinical imaging, our in vitro setup 
allowed us to set the imaging distance and hence accurately measure the color intensity of our thrombus models. As Fig 5  shows, little 
discriminant information is provided by the accurate knowledge of intensity value; its exclusion from the final computational model is therefore 
of little consequence. 
Colorimetry and Thrombus Composition 
The relation of colorimetric values and thrombus model number is graphically depicted in Fig 4 . The plateau effect of C1 and C2 found at 
higher preclot concentrations of erythrocytes would at first glance appear to limit the usefulness of the technique in distinguishing between 
erythrocyte-rich thrombi. The explanation for this observation, though, appears to lie with differences in size of the formed thrombus models. 
Although each model was constructed from equal preclot volumes, Fig 9  shows that the final clot mass generally decreased with increasing 
thrombus number. This phenomenon likely resulted from the relative effectiveness of platelet-induced clot retraction. In thrombi containing a 
large concentration of erythrocytes, the ability of platelets to coalesce and extrude entrapped serum could be hampered by the presence of the 
bulky cells, resulting in a larger thrombus. To correct for this effect, colorimetric values were compared with the number of erythrocytes 
contained within each nanogram of formed thrombus (Fig 10 ). Not only was a significant curvilinear relation achieved (r>.99), but no plateau 
was observed. These findings support the utility of quantitative colorimetric analysis in distinguishing thrombi over the entire achievable range 
of erythrocyte thrombus concentrations. 
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Figure 10. Semilogarithmic scatterplot of relation between quantitative colorimetric values 
and the concentration of erythrocytes (by weight) contained within each thrombus model. 
Values represent means of four measurements recorded at four different illumination light 
intensities. Note that the outlier (No. 14) excluded from Fig 2  is included in this plot (fifth 
point from left). The dashed lines represent second-order polynomial regression functions; 
parameters for C1 include r=.99 with coefficients of 0.695, 0.290, and -0.108, and parameters 
for C2 include r=.99 with coefficients of 0.107, -0.136, and 0.062.
Fig 10  also includes the outlier, thrombus model 14. This thrombus retained a disproportionate volume of serum during its formation (Fig 9 ). 
Although the resulting measured C1 value was 22% lower than expected from the relation shown in Fig 4 , this apparent error was completely 
eliminated by the use of thrombus erythrocyte concentration as the independent variable. 
The colorimetric values obtained were also examined for thrombus erythrocyte content, thrombus hemoglobin content, thrombus hemoglobin 
concentration, and erythrocyte/platelet ratio. All these relations proved inferior to the thrombus erythrocyte concentration in the strength of their 
correlation to measured colorimetric values. 
Interrelations of Colorimetric Parameters 
A nearly linear relationship between C1 and C2 is evident in Fig 7 . This finding is most commonly noted in the field of colorimetry when two 
pure colors are mixed in progressive proportions. This physical concept appears quite analogous to our current model involving progressive 
erythrocyte concentrations. 
In addition to its physical implications, the observed linear relationship in C1 and C2 provides the opportunity of simplifying the predictive 
model and enhancing clinical applicability. In analogy to the three types of cones in the human retina, tristimulus colorimetry can completely 
describe any color with the use of three variables, such as RGB or HSI. We have gone one step further in the C1/C2 chromaticity scale by 
eliminating the contribution of intensity in the description of color, a step that has few practical consequences in angioscopy because of the 
marked dependence of this parameter on illumination brightness. A two-parameter system of angioscopic color description is still awkward, 
though, because it requires the use of two numeric values for every color measurement, making comparisons particularly difficult. When 
quantitative colorimetric angioscopic analysis is used in the study of thrombus, our data suggest that transformation from a two-dimensional to a 
single-dimensional description of color using principal components analysis is possible with minimal (0.06%) loss of content. Thrombus can 
therefore be accurately characterized with a single parameter, the thrombus erythrocyte index. 
Potential Limitations 
It is important to note several possible limitations of our investigation. First, all the thrombus models were created under static conditions. In 
contrast, a sizable proportion of arterial thrombi form in vivo in continuity with flowing blood. This milieu frequently leads to thrombi 
composed of laminations of relatively erythrocyte-rich and platelet-rich material.44 Although dynamic models are available for the formation of 
layered thrombi, they were not used in the current investigation because the resulting heterogeneity of composition and color would preclude an 
accurate comparison of these two parameters. 
Second, because of the desire to carefully control thrombus formation and composition, testing was not extended to other potential in vitro and 
in vivo thrombus models. Though unproven, extrapolation of our results to other types of thrombus appears rational, because colorimetry relies 
on physical rather than biochemical properties of the interrogated material. 
Finally, although the focus of the current study was the relative contribution of erythrocytes, thrombus color may be potentially influenced by 
the relative amounts of platelets and fibrin as well. This issue is currently being explored in depth in our laboratory. 
Clinical Implications 
With increasing recognition of the importance of thrombus in heart disease comes the need for its improved identification and quantification. 
Although modern diagnostic techniques may be marginally useful in detecting thrombus, they cannot provide information on composition. 
Knowledge of composition may prove to be especially useful in assessing likely outcomes or establishing optimal treatment. 
Our system of quantitative colorimetric angioscopic analysis provides an accurate and reproducible method of determining the concentration of 
erythrocytes in these thrombus models using a single derived colorimetric parameter. It is clearly superior to the eye of a trained observer in this 
task and avoids the variability in visual perception created by differing illuminating light intensities. This relatively inexpensive tool is available 
on-line for rapid analysis within seconds and can, for the first time, provide quantitative information during routine angioscopic imaging. 
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